We have been actively participating in successful clinical trials since 1978. Our headache database, which contains over 5500 patients, has expanded tremendously over the years. Our site has been involved in landmark studies leading to FDA licensing of all triptan medications marketed thus far, and we are currently conducting additional studies on three other such medications, as well as headache prophylactic medications. We have expanded our clinical research center significantly to involve Alzheimer's prophylaxis and treatment, stroke, acute back pain, anxiety, depression and most other neurological conditions. Our patients are familiar with study requirements and are very compliant.
Every patient receives the highest quality medical care.
We notify the patient's primary care physician of enrollment and ongoing status and provide a full report at the conclusion of each study. Dr. Jerome Goldstein graduated from the Upstate Medical Center in Syracuse, New York and completed his Neurology residency at the University of California in San Francisco in 1970. He is certified by the American Board of Psychiatry and Neurology and is the Director of the San Francisco Clinical Research Center, the San Francisco Headache Clinic and the San Francisco Alzheimer's and Dementia Clinic . Dr. Goldstein has authored many research publications in the field of headache. He is a pioneer on multimedia scientific and educational presentations on pain and headache, especially the general nature of headache, the comparison of the 5-HT 1D receptor agonists, the role of opiates in pain and headache management.